US-based biotech firm Capricor Therapeutics has entered into a partnership with Nippon Shinyaku Co., a Japanese pharmace...
Applications of new molecules as drugs are expected to be effective in treating diseases that are difficult to cure with...
NTT Corporation and the University of Tokyo in Japan have devised a new learning algorithm inspired by the informat...
Astellas Pharma Inc. has approved changes to its Representative Director, President and Chief Executive Officer (CEO) an...
Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC) and Nagasaki University, Japan, have developed a digital...
Japan-based Mitsubishi Chemical Group has decided to cease all of its operations at Medicago Inc., a Canadian subs...
US-based firm Invivoscribe has announced the appointment of Masato Sasaki as General Manager of LabPMM GK, its refe...
Japan headquartered pharmaceutical company Shionogi & Co. and its European subsidiary, Shionogi B.V. have announced ...
Daiichi Sankyo Company has announced the appointment of a new President & Chief Operating Officer (COO) effect...
Japan-headquartered Ono Pharmaceutical has entered an agreement with US-based KSQ Therapeutics, a clinical-stage biotech...
Japan-headquartered Shimadzu Corporation has announced the release of the world’s smallest MALDI-TOF imaging solut...
Aculys Pharma, Inc., a company focused on the development and commercialisation of new innovative drugs in the fields of...
Japan-headquartered Astellas Pharma has entered into an Asset Purchase Agreement, under which Astellas will transfer the...
Japanese pharmaceutical firm Takeda has entered into an exclusive licensing agreement with Hutchmed (China) for the furt...
Japan headquartered firm Eisai has launched its pharmaceutical sales subsidiary, a fully-fledged operations and bus...
Tokyo Headquarterd Kaneka Corporation is set to increase its GMP manufacturing capacity for mRNA in ...
European biotech firm Alvotech and Japanese pharmaceutical company Fuji Pharma have decided to expand their existing exc...
US-based Selecta Biosciences, and Japanese firm Astellas Pharma have announced an exclusive licensing and development ag...
